Table 4.
Prevalence of Pfdhfr and Pfdhps haplotypes
Study sites | Years |
Pfdhfr
|
Pfdhps
|
Pfdhfr+Pfdhps
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | ICNI (%) | IRNI (%) | NCNI (%) | NCSI (%) | p-value | N | AAKAA (%) | AGKAA (%) | SGKAA (%) | SAKAA (%) | p-value | N | Quadruple (%) | p-value | ||
Franceville | 2011 | 15 | 0.0 | 100.0 | 0.0 | 0.0 | 0.6 | 4 | 0.0 | 0.0 | 100.0 | 0.0 | 0.48 | 3 | 100.0 | 0.32 |
2012 | 23 | 0.0 | 95.7 | 4.3 | 0.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 | ||||
2013 | 22 | 0.0 | 100.0 | 0.0 | 0.0 | 12 | 0.0 | 8.3 | 83.3 | 8.3 | 12 | 100.0 | ||||
2014 | 19 | 5.3 | 89.4 | 0.0 | 0.0 | 10 | 10.0 | 30.0 | 50.0 | 10.0 | 9 | 88.9 | ||||
Koulamoutou | 2013 | 23 | 0.0 | 100.0 | 0.0 | 0.0 | 1 | 19 | 15.8 | 0.0 | 68.4 | 15.8 | 0.33 | 15 | 73.3 | 0.32 |
2014 | 26 | 0.0 | 100.0 | 0.0 | 0.0 | 22 | 8.3 | 8.3 | 83.3 | 0.0 | 12 | 91.7 | ||||
Lastourville | 2013 | 29 | 0.0 | 96.6 | 0.0 | 3.4 | 1 | 22 | 4.6 | 0.0 | 86.4 | 9.1 | 0.24 | 24 | 83.3 | 0.32 |
2014 | 17 | 0.0 | 94.1 | 0.0 | 5.9 | 7 | 14.3 | 14.3 | 71.4 | 0.0 | 7 | 100.0 | ||||
All sites | 2013 | 74 | 0.0 | 98.6 | 0.0 | 1.4 | 0.54 | 53 | 6.9 | 1.7 | 72.4 | 19 | 0.05 | 51 | 80.4 | 1 |
2014 | 62 | 1.6 | 95.2 | 0.0 | 1.6 | 29 | 9.7 | 16.1 | 64.5 | 9.7 | 28 | 92.9 |
Note: Quadruple mutations = Pfdhfr (51+59+108) and Pfdhps (437).